Consensus Rezolute, Inc.

Stocks

RZLT

US76200L3096

Biotechnology & Medical Research

Market Closed - Nasdaq 16:00:00 2026-09-04 EDT			5-day change	1st Jan Change
4.580 ^USD	+0.88%		-0.87%	+94.07%

08-25	Rezolute Shares to Show Strength Towards Upcoming Ersodetug Catalysts, Wedbush Says	MT
06-17	Rezolute, Inc. Highlights Results from Natural History Outcomes Studies and Its Ersodetug Clinical Program in Hyperinsulinism At Annual Meeting of the Endocrine Society	CI

Evolution of the Average Target: Rezolute, Inc.

Evolution of the Target Price: Rezolute, Inc.

Changes in Analyst Recommendations: Rezolute, Inc.

ba7965.5Y-ZrTqsbnvBXyN486ijBUyX1GR5I-KBpaJjrULndBg.oe7y72vBCCqqPhEJysrgbwrFogwoS4bs0cUK5DqINnKSyKneTMQPN4sleg~bfffa77af2102b7a1a4b06f4b4dda646

Analysts' recommendations: Rezolute, Inc.

08-25	Rezolute Shares to Show Strength Towards Upcoming Ersodetug Catalysts, Wedbush Says	MT
06-03	Wedbush Adjusts Price Target on Rezolute to $6 From $5, Maintains Outperform Rating	MT
03-25	Wedbush Upgrades Rezolute to Outperform From Neutral, Raises Price Target to $5 From $2	MT
01-08	Wedbush Doubles Price Target on Rezolute to $2 From $1, Keeps Neutral Rating	MT
12-12	Craig-Hallum Downgrades Rezolute to Hold From Buy, Adjusts PT to $2 From $18	MT
12-11	Wedbush Downgrades Rezolute to Neutral From Outperform, Price Target is $1	MT
25-09-17	Rezolute Q4 net loss widens to $24.4 mln	RE
24-11-05	Wedbush Initiates Rezolute at Outperform With $12 Price Target	MT
24-08-27	Guggenheim Initiates Rezolute at Buy With $11 Price Target	MT
24-07-17	BTIG Initiates Rezolute at Buy With $13 Price Target	MT
24-06-04	Craig-Hallum Initiates Rezolute at Buy Rating With $14 Price Target	MT
24-04-18	JonesTrading Starts Rezolute With Buy Rating, $10 Price Target	MT
23-11-14	JMP Securities Adjusts Price Target on Rezolute to $7 From $8, Maintains Market Outperform Rating	MT
23-06-28	Cantor Fitzgerald Adjusts Price Target on Rezolute to $5 From $7, Maintains Overweight Rating	MT
23-05-19	Canaccord Genuity Adjusts Price Target on Rezolute to $17 From $16, Maintains Buy Rating	MT
23-02-14	HC Wainwright Trims Price Target on Rezolute to $17 From $21, Maintains Buy Rating	MT
22-09-12	Jefferies Initiates Rezolute at Buy With $11 Price Target	MT
22-08-02	Canaccord Genuity Assumes Rezolute at Buy with $17 Price Target	MT
22-06-15	Cantor Fitzgerald Starts Rezolute at Overweight With $9 Price Target	MT
22-05-10	Oppenheimer Adjusts Rezolute Price Target to $23 From $25, Maintains Outperform Rating	MT
21-11-29	Canaccord Genuity Adjusts Price Target on Rezolute to $17 From $30, Maintains Buy Rating	MT
21-11-15	JMP Securities Adjusts Price Target on Rezolute to $18 From $30, Keeps Market Outperform Rating	MT
21-09-08	Rezolute : Roth Capital Initiates Coverage on Rezolute With Buy Rating, $21 Price Target	MT
21-05-27	Rezolute : Oppenheimer Initiates Coverage on Rezolute With Outperform Rating, $25 Price Target	MT
21-05-25	Rezolute : HC Wainwright Starts Rezolute at Buy With $21 Price Target	MT